Patents by Inventor Julian Kenyon

Julian Kenyon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230089740
    Abstract: The present invention relates to compositions, methods, uses and kits for treating cancer. The present invention relates to methods for minimising the progression of cancer in a subject, the method comprising administering to the subject therapeutically effective amounts of chymotrypsinogen and trypsinogen, thereby minimising the progression of cancer in the subject. In particular, the methods provide a means for treating cancer by reducing the number of cancer stem cells in the subject.
    Type: Application
    Filed: June 3, 2022
    Publication date: March 23, 2023
    Applicant: Propanc Pty Ltd
    Inventors: Macarena Perán Quesada, Julian Kenyon, Juan Antonio Marchal Corrales, Maria Angel Garcia Chaves
  • Patent number: 11376313
    Abstract: The present invention relates to compositions, methods, uses and kits for treating cancer. The present invention relates to methods for minimising the progression of cancer in a subject, the method comprising administering to the subject therapeutically effective amounts of chymotrypsinogen and trypsinogen, thereby minimising the progression of cancer in the subject. In particular, the methods provide a means for treating cancer by reducing the number of cancer stem cells in the subject.
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: July 5, 2022
    Assignee: PROPANC PTY LTD
    Inventors: Macarena Perán Quesada, Julian Kenyon, Juan Antonio Marchal Corrales, Maria Angel Garcia Chaves
  • Publication number: 20190262435
    Abstract: The present invention relates to compositions, methods, uses and kits for treating cancer. In particular, the invention relates to compositions and methods of treating cancer in a subject comprising administering chymotrypsinogen in certain amounts, for example greater than about 0.1 mg/kg, and trypsinogen in an amount, for example, greater than about 0.02 mg/kg, thereby treating cancer. The invention also relate to compositions and methods for treating cancer in a subject comprising chymotrypsinogen and trypsinogen wherein the weight ratio of chymotrypsinogen:trypsinogen is greater than 8:1.
    Type: Application
    Filed: November 11, 2016
    Publication date: August 29, 2019
    Inventors: Julian Kenyon, Ralf Brandt
  • Publication number: 20190134166
    Abstract: The present invention relates to compositions, methods, uses and kits for treating cancer. In particular, the invention relates to compositions and methods of treating cancer in a subject comprising administering chymotrypsinogen in certain amounts, for example a weight ratio of chymotrypsinogen:trypsinogen is greater than 1:1 but less than 4:1, thereby treating cancer.
    Type: Application
    Filed: April 12, 2017
    Publication date: May 9, 2019
    Applicant: Propanc Pty Ltd
    Inventors: Julian Kenyon, Ralf Brandt
  • Publication number: 20190038725
    Abstract: The present invention relates to compositions, methods, uses and kits for treating cancer. The present invention relates to methods for minimising the progression of cancer in a subject, the method comprising administering to the subject therapeutically effective amounts of chymotrypsinogen and trypsinogen, thereby minimising the progression of cancer in the subject. In particular, the methods provide a means for treating cancer by reducing the number of cancer stem cells in the subject.
    Type: Application
    Filed: January 27, 2017
    Publication date: February 7, 2019
    Inventors: Macarena Peran, Julian Kenyon, Juan Antonio Marchal Corrales, Maria Angel Garcia Chaves